The efficacy of short daily dialysis--a single-centre experience.
Studies have shown that patients converted to short daily haemodialysis (SDHD) have reported many clinical benefits, decreased complications during dialysis and a better quality of life.A six-month prospective cohort study was conducted to examine the efficacy of SDHD to patients previously receiving three times per week haemodialysis therapy. Following informed consent, participants received haemodialysis daily, Monday-Saturday, between 2 and 2.5 hours for each treatment and followed-up for a six-month period. The participants continued to experience hypotension, cramping and headache and were noncompliant with fluid intake. There was a gradual reduction in blood pressure, cessation of antihypertensives and reduction of erythropoietin therapy (ERT). There were no hospital admissions or reports of access complications. The nursing staff reported an increase in activity levels and nursing interventions with the participants following conversion to SDHD. However, the participants reported a better quality of life.
Rayment
Glenda
G
Renal Unit, Liverpool Hospital, Liverpool, NSW, Australia. glenda.rayment@sswahs.nsw.gov.au
Chow
Josephine
J
D000328:Adult; D000368:Aged; D001291:Attitude of Health Personnel; D001315:Australia; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods* / Q000451:nursing; D013997:Time Factors; D016896:Treatment Outcome